IP Library › Granted Patent US 8,569,487
Granted Patent B2
US 8,569,487 · App. 12/303,207 · Granted Oct 29, 2013

Pyridazine compound and use thereof

Inventors: Steven S. Bondy (Danville, CA); Terrence C. Dahl (Sunnyvale, CA); David A. Oare (Belmont, CA); Reza Oliyai (Burlingame, CA); Winston C. Tse (San Mateo, CA); Vahid Zia (San Carlos, CA)
Assignees: Gilead Sciences, Inc.; K.U. Leuven Research & Development; Gerhard Puerstinger
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,569,487
App. No.
12/303,207
Granted
Oct 29, 2013
Kind
B2
Abstract

A compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections. Methods of making and formulating compound (1) are provided.

Claims (2)

1. A compound of formula (3)

and its analogues substituted with methyl rather than chloromethyl; and bromo, fluoro or iodo in place of chloro.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2015
From: GILEAD SCIENCES, INC.
To: K.U. LEUVEN RESEARCH & DEVELOPMENT
Reel/Frame 036495/0004 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2009
From: BONDY, STEVEN S.; DAHL, TERRENCE C.; OARE, DAVID A.; OLIYAI, REZA; TSE, WINSTON C.; ZIA, VAHID
To: GILEAD SCIENCES, INC.; K.U. LEUVEN RESEARCH & DEVELOPMENT; PUERSTINGER, GERHARD
Reel/Frame 023314/0802 →
Continuity (4)
Provisional Application 60819289 · Jul 7, 2006
Provisional Application 60832403 · Jul 21, 2006
Provisional Application 60832769 · Jul 24, 2006
Related Publication 20100063059A1 · Mar 11, 2010